Show simple item record

dc.contributor.authorLobitz, Stephanen
dc.contributor.authorTelfer, Paulen
dc.contributor.authorCela, Elenaen
dc.contributor.authorAllaf, Bichren
dc.contributor.authorAngastiniotis, Michaelen
dc.contributor.authorBackman Johansson, Carolinaen
dc.contributor.authorBadens, Catherineen
dc.contributor.authorBento, Celesteen
dc.contributor.authorBouva, Marelle Jen
dc.contributor.authorCanatan, Duranen
dc.contributor.authorCharlton, Matthewen
dc.contributor.authorCoppinger, Cathyen
dc.contributor.authorDaniel, Yvonneen
dc.contributor.authorde Montalembert, Marianneen
dc.contributor.authorDucoroy, Patricken
dc.contributor.authorDulin, Elenaen
dc.contributor.authorFingerhut, Ralphen
dc.contributor.authorFrömmel, Claudiaen
dc.contributor.authorGarcía-Morin, Marinaen
dc.contributor.authorGulbis, Béatriceen
dc.contributor.authorHoltkamp, Uteen
dc.contributor.authorInusa, Babaen
dc.contributor.authorJames, Johnen
dc.contributor.authorKleanthous, Marinaen
dc.contributor.authorKlein, Jeannetteen
dc.contributor.authorKunz, Joachim Ben
dc.contributor.authorLangabeer, Lisaen
dc.contributor.authorLapouméroulie, Claudineen
dc.contributor.authorMarcao, Anaen
dc.contributor.authorMarín Soria, José Len
dc.contributor.authorMcMahon, Corrinaen
dc.contributor.authorOhene-Frempong, Kwakuen
dc.contributor.authorPérini, Jean-Marcen
dc.contributor.authorPiel, Frédéric Ben
dc.contributor.authorRusso, Giovannaen
dc.contributor.authorSainati, Lauraen
dc.contributor.authorSchmugge, Markusen
dc.contributor.authorStreetly, Allisonen
dc.contributor.authorTshilolo, Leonen
dc.contributor.authorTurner, Charlesen
dc.contributor.authorVenturelli, Donatellaen
dc.contributor.authorVilarinho, Lauraen
dc.contributor.authorYahyaoui, Rachelen
dc.contributor.authorElion, Jacquesen
dc.contributor.authorColombatti, Raffaellaen
dc.date.accessioned2018-11-20T09:36:34Z
dc.date.available2018-11-20T09:36:34Z
dc.date.issued2018-10-18
dc.identifier.citationNewborn screening for sickle cell disease in Europe: recommendations from a Pan-European Consensus Conference. 2018 Br. J. Haematol.en
dc.identifier.issn1365-2141
dc.identifier.pmid30334577
dc.identifier.doi10.1111/bjh.15600
dc.identifier.urihttp://hdl.handle.net/10029/622290
dc.description.abstractSickle Cell Disease (SCD) is an increasing global health problem and presents significant challenges to European health care systems. Newborn screening (NBS) for SCD enables early initiation of preventive measures and has contributed to a reduction in childhood mortality from SCD. Policies and methodologies for NBS vary in different countries, and this might have consequences for the quality of care and clinical outcomes for SCD across Europe. A two-day Pan-European consensus conference was held in Berlin in April 2017 in order to appraise the current status of NBS for SCD and to develop consensus-based statements on indications and methodology for NBS for SCD in Europe. More than 50 SCD experts from 13 European countries participated in the conference. This paper aims to summarise the discussions and present consensus recommendations which can be used to support the development of NBS programmes in European countries where they do not yet exist, and to review existing programmes.
dc.language.isoenen
dc.rightsinfo:eu-repo/semantics/closedAccessen
dc.titleNewborn screening for sickle cell disease in Europe: recommendations from a Pan-European Consensus Conference.en
dc.typeArticleen
dc.identifier.journalBr J Haematol 2018; 183(4):648-660en
html.description.abstractSickle Cell Disease (SCD) is an increasing global health problem and presents significant challenges to European health care systems. Newborn screening (NBS) for SCD enables early initiation of preventive measures and has contributed to a reduction in childhood mortality from SCD. Policies and methodologies for NBS vary in different countries, and this might have consequences for the quality of care and clinical outcomes for SCD across Europe. A two-day Pan-European consensus conference was held in Berlin in April 2017 in order to appraise the current status of NBS for SCD and to develop consensus-based statements on indications and methodology for NBS for SCD in Europe. More than 50 SCD experts from 13 European countries participated in the conference. This paper aims to summarise the discussions and present consensus recommendations which can be used to support the development of NBS programmes in European countries where they do not yet exist, and to review existing programmes.


This item appears in the following Collection(s)

Show simple item record